349 related articles for article (PubMed ID: 23076968)
1. Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
Sorajja P; Ommen SR; Holmes DR; Dearani JA; Rihal CS; Gersh BJ; Lennon RJ; Nishimura RA
Circulation; 2012 Nov; 126(20):2374-80. PubMed ID: 23076968
[TBL] [Abstract][Full Text] [Related]
2. Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
Sorajja P; Binder J; Nishimura RA; Holmes DR; Rihal CS; Gersh BJ; Bresnahan JF; Ommen SR
Catheter Cardiovasc Interv; 2013 Jan; 81(1):E58-67. PubMed ID: 22511295
[TBL] [Abstract][Full Text] [Related]
3. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
[TBL] [Abstract][Full Text] [Related]
4. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
Sorajja P; Valeti U; Nishimura RA; Ommen SR; Rihal CS; Gersh BJ; Hodge DO; Schaff HV; Holmes DR
Circulation; 2008 Jul; 118(2):131-9. PubMed ID: 18591440
[TBL] [Abstract][Full Text] [Related]
5. Alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: low incidence of sudden cardiac death and reduced risk profile.
Jensen MK; Prinz C; Horstkotte D; van Buuren F; Bitter T; Faber L; Bundgaard H
Heart; 2013 Jul; 99(14):1012-7. PubMed ID: 23644300
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes after medical and invasive treatment in patients with hypertrophic cardiomyopathy.
Vriesendorp PA; Liebregts M; Steggerda RC; Schinkel AF; Willems R; Ten Cate FJ; van Cleemput J; Ten Berg JM; Michels M
JACC Heart Fail; 2014 Dec; 2(6):630-6. PubMed ID: 25447346
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy.
Ommen SR; Maron BJ; Olivotto I; Maron MS; Cecchi F; Betocchi S; Gersh BJ; Ackerman MJ; McCully RB; Dearani JA; Schaff HV; Danielson GK; Tajik AJ; Nishimura RA
J Am Coll Cardiol; 2005 Aug; 46(3):470-6. PubMed ID: 16053960
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution.
ten Cate FJ; Soliman OI; Michels M; Theuns DA; de Jong PL; Geleijnse ML; Serruys PW
Circ Heart Fail; 2010 May; 3(3):362-9. PubMed ID: 20332420
[TBL] [Abstract][Full Text] [Related]
9. Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: comparative rates of overall mortality and sudden cardiac death after treatment.
Leonardi RA; Kransdorf EP; Simel DL; Wang A
Circ Cardiovasc Interv; 2010 Apr; 3(2):97-104. PubMed ID: 20197511
[TBL] [Abstract][Full Text] [Related]
10. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general population.
Veselka J; Krejčí J; Tomašov P; Zemánek D
Eur Heart J; 2014 Aug; 35(30):2040-5. PubMed ID: 24464834
[TBL] [Abstract][Full Text] [Related]
12. Survival and sudden cardiac death after septal ablation for hypertrophic obstructive cardiomyopathy.
Jensen MK; Havndrup O; Hassager C; Helqvist S; Kelbæk H; Jørgensen E; Køber L; Bundgaard H
Scand Cardiovasc J; 2011 Jun; 45(3):153-60. PubMed ID: 21604920
[TBL] [Abstract][Full Text] [Related]
13. Periprocedural complications and long-term outcome after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy: a single-center experience.
Steggerda RC; Damman K; Balt JC; Liebregts M; ten Berg JM; van den Berg MP
JACC Cardiovasc Interv; 2014 Nov; 7(11):1227-34. PubMed ID: 25326737
[TBL] [Abstract][Full Text] [Related]
14. Does myectomy convey survival benefit in hypertrophic cardiomyopathy?
Woo A; Rakowski H
Heart Fail Clin; 2007 Jul; 3(3):275-88. PubMed ID: 17723936
[TBL] [Abstract][Full Text] [Related]
15. Early outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a European multicenter and multinational study.
Veselka J; Lawrenz T; Stellbrink C; Zemanek D; Branny M; Januska J; Sitar J; Dimitrow P; Krejci J; Dabrowski M; Mizera S; Bartel T; Kuhn H
Catheter Cardiovasc Interv; 2014 Jul; 84(1):101-7. PubMed ID: 24285605
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy in the Young and the Elderly.
Liebregts M; Steggerda RC; Vriesendorp PA; van Velzen H; Schinkel AF; Willems R; van Cleemput J; van den Berg MP; Michels M; ten Berg JM
JACC Cardiovasc Interv; 2016 Mar; 9(5):463-9. PubMed ID: 26965935
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy.
Sedehi D; Finocchiaro G; Tibayan Y; Chi J; Pavlovic A; Kim YM; Tibayan FA; Reitz BA; Robbins RC; Woo J; Ha R; Lee DP; Ashley EA
J Cardiol; 2015 Jul; 66(1):57-62. PubMed ID: 25238885
[TBL] [Abstract][Full Text] [Related]
18. Outcome of surgical myectomy after unsuccessful alcohol septal ablation for the treatment of patients with hypertrophic obstructive cardiomyopathy.
Nagueh SF; Buergler JM; Quinones MA; Spencer WH; Lawrie GM
J Am Coll Cardiol; 2007 Aug; 50(8):795-8. PubMed ID: 17707185
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival in patients with resting obstructive hypertrophic cardiomyopathy comparison of conservative versus invasive treatment.
Ball W; Ivanov J; Rakowski H; Wigle ED; Linghorne M; Ralph-Edwards A; Williams WG; Schwartz L; Guttman A; Woo A
J Am Coll Cardiol; 2011 Nov; 58(22):2313-21. PubMed ID: 22093509
[TBL] [Abstract][Full Text] [Related]
20. Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy.
Smedira NG; Lytle BW; Lever HM; Rajeswaran J; Krishnaswamy G; Kaple RK; Dolney DO; Blackstone EH
Ann Thorac Surg; 2008 Jan; 85(1):127-33. PubMed ID: 18154797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
